Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2

Status

Unknown 17Not yet recruiting 8Completed 8Recruiting 6Active not recruiting 2Terminated 1

Sponsor Class

OTHER 163INDUSTRY 69OTHER_GOV 6NIH 3NETWORK 3

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 3Gastrointestinal 2NET 1Endocrine 1

Conditions

Breast Neoplasms 2Neuroendocrine Tumors 1Locally Advanced Rectal Cancer With Liver Metastases 1Colorectal Neoplasms 1Advanced Breast Cancer 1

Interventions

Drug Therapy 10pembrolizumab 9Bevacizumab 9Radiotherapy 8Cyclophosphamide 8Carboplatin 8Oxaliplatin 7tislelizumab 6Surgical Procedures, Operative 6Docetaxel 6Cisplatin 6Capecitabine 6Paclitaxel 5Nivolumab 5Fluorouracil 5Control Groups 5fludarabine 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Capecitabine × Clear all
NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Fujian Cancer Hospital

Phase 3 Recruiting
258 enrolled
Breast

Breast Neoplasms

NCT06787183 2026-03-03

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Fujian Cancer Hospital

Phase 2 Recruiting
42 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer With Liver Metastases

NCT07185672 2025-09-22

PReCedeNT

Tata Memorial Hospital

Phase 3 Recruiting
162 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06888843 2025-03-27

AHTCRR-1

Nizhny Novgorod Regional Clinical Oncology Center

Phase 2 Recruiting
160 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06598046 2024-09-19

A Single-arm, Prospective Phase â…¡ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

Henan Cancer Hospital

Phase 2 Recruiting
48 enrolled
Breast

Breast Neoplasms

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase â…¡ Clinical Trial

Henan Cancer Hospital

Phase 2 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡